Home LiteratureArticle Details
PMID: 21126329 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.

BMC immunology ·Vol. 11 ·2010-12-02 ·Pages 58

Kolbus D, Ramos OH, Berg KE, Persson J, Wigren M, Björkbacka H, Fredrikson GN, Nilsson J

Abstract

It is well established that adaptive immune responses induced by hypercholesterolemia play an important role in the development of atherosclerosis, but the pathways involved remain to be fully characterized. In the present study we assessed immune responses to hypercholesterolemia induced by feeding Apoe-/- mice a high-fat diet for 4 or 8 weeks. The primary immune response in lymph nodes draining the aortic root was an increased expression of interferon (IFN)-γ in CD8(+)CD28(+) T cells, while an activation of IFN-γ expression in CD4(+) T cells was observed only after 8 weeks of high-fat diet. Contrarily, spleen CD4(+) T cells responded with a higher expression of IL-10. Spleen CD8(+) T cells expressed both IFN-γ and IL-10 and showed enhanced proliferation when exposed to Concanavalin A. Plasma levels of IgG and IgM against oxidized LDL did not change, but the level of apolipoprotein B/IgM immune complexes was increased. Hypercholesterolemia leads to unopposed activation of Th1 immune responses in lymph nodes draining atherosclerotic lesions, whereas Th1 activation in the spleen is balanced by a concomitant activation of Th2 cells. The activation of CD8(+) T cells implies that hypercholesterolemia is associated with formation of cell autoantigens.

MeSH Terms
Animals Atherosclerosis/etiology,immunology,metabolism,pathology CD28 Antigens/biosynthesis CD4-Positive T-Lymphocytes/drug effects,immunology,metabolism,pathology CD8-Positive T-Lymphocytes/immunology,metabolism,pathology Cells, Cultured Cholesterol, Dietary/adverse effects Diet, Atherogenic Hypercholesterolemia/etiology,immunology,metabolism,pathology Interferon-gamma/metabolism Interleukin-10/metabolism Low Density Lipoprotein Receptor-Related Protein-1/genetics Lymphocyte Activation Mice Mice, Knockout
Chemicals
CD28 Antigens Cholesterol, Dietary Low Density Lipoprotein Receptor-Related Protein-1 Interleukin-10 Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kolbus Daniel
Department of Clinical Sciences, Skane University Hospital Malmö, Lund University, Sweden. [email protected]
Ramos Ornélia H
Berg Katarina E
Persson Josefin
Wigren Maria
Björkbacka Harry
Fredrikson Gunilla Nordin
Nilsson Jan
References (40)
40 references, click to expand
  1. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice.
    Am J Pathol. 2004 Dec;165(6):2013-8 PMID: 15579444
  2. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.
    Cardiovasc Res. 2010 Feb 1;85(3):622-30 PMID: 19819882
  3. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Clin Chim Acta. 2004 Oct;348(1-2):1-8 PMID: 15369729
  4. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Circulation. 2007 Oct 16;116(16):1832-44 PMID: 17938300
  5. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):879-84 PMID: 12649092
  6. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):108-14 PMID: 11145941
  7. Inflammation, atherosclerosis, and coronary artery disease.
    N Engl J Med. 2005 Apr 21;352(16):1685-95 PMID: 15843671
  8. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis.
    J Intern Med. 2000 Mar;247(3):371-80 PMID: 10762454
  9. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.
    Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10679-84 PMID: 15249654
  10. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
    Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3893-7 PMID: 7732003
  11. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
    Biochem Biophys Res Commun. 2005 Dec 30;338(4):1982-9 PMID: 16288717
  12. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    J Clin Invest. 1996 Aug 1;98(3):800-14 PMID: 8698873
  13. Requirements for CD8 T-cell migration into the human arterial wall.
    Hum Pathol. 2008 Dec;39(12):1756-62 PMID: 18706675
  14. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.
    Am J Pathol. 1996 Aug;149(2):359-66 PMID: 8701976
  15. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.
    Circulation. 2007 Apr 24;115(16):2168-77 PMID: 17420351
  16. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
    Circulation. 2003 Sep 9;108(10):1232-7 PMID: 12912803
  17. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
    J Clin Invest. 1997 Jun 1;99(11):2752-61 PMID: 9169506
  18. Immunomodulation of atherosclerosis: implications for vaccine development.
    Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):18-28 PMID: 15514204
  19. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis.
    Circulation. 2005 Aug 16;112(7):1054-62 PMID: 16103256
  20. Atherosclerotic lesions in mouse and man: is it the same disease?
    Curr Opin Lipidol. 2010 Oct;21(5):434-40 PMID: 20683327
  21. Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice.
    Atherosclerosis. 2010 Apr;209(2):436-41 PMID: 19897195
  22. Natural regulatory T cells control the development of atherosclerosis in mice.
    Nat Med. 2006 Feb;12(2):178-80 PMID: 16462800
  23. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide.
    J Lipid Res. 2006 Sep;47(9):2049-54 PMID: 16809787
  24. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    J Intern Med. 2008 Dec;264(6):563-70 PMID: 18783480
  25. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.
    J Clin Invest. 2002 Mar;109(6):745-53 PMID: 11901183
  26. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
    J Clin Invest. 1998 Apr 15;101(8):1717-25 PMID: 9541503
  27. Innate and acquired immunity in atherogenesis.
    Nat Med. 2002 Nov;8(11):1218-26 PMID: 12411948
  28. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.
    Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1596-601 PMID: 15665085
  29. Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):864-70 PMID: 16456097
  30. Atherosclerosis. the road ahead.
    Cell. 2001 Feb 23;104(4):503-16 PMID: 11239408
  31. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.
    Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12752-7 PMID: 11050173
  32. Autoimmunity in atherosclerosis: a protective response losing control?
    J Intern Med. 2008 May;263(5):464-78 PMID: 18410590
  33. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.
    J Clin Invest. 2004 Aug;114(3):427-37 PMID: 15286809
  34. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: arteritis or atherosclerosis?
    Arthritis Rheum. 2006 Mar;54(3):908-13 PMID: 16508973
  35. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.
    Circulation. 2009 May 5;119(17):2367-75 PMID: 19380622
  36. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.
    Nat Med. 2004 Apr;10(4):416-21 PMID: 15034566
  37. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Circ Res. 2008 Oct 24;103(9):965-73 PMID: 18832748
  38. Modulation of atherosclerosis in mice by Toll-like receptor 2.
    J Clin Invest. 2005 Nov;115(11):3149-56 PMID: 16211093
  39. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis.
    Circ Res. 2000 Jun 23;86(12):1203-10 PMID: 10864909
  40. Induction of T-cell activation by oxidized low density lipoprotein.
    Arterioscler Thromb. 1992 Apr;12(4):461-7 PMID: 1558837
Article Info
Journal
BMC immunology
Abbr.
BMC Immunol
ISSN
1471-2172
Published
2010-12-02
Epub
2010-00-02
Pages
58
Language
English
Region
England
NLM ID
100966980
PMCID
PMC3003229
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]